PHAT PHATHOM PHARMACEUTICALS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 13 analyst firms say about PHATHOM PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
12 rated views · 14 analyst/firm records · 13 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8070
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8045
Recent analyst activity · last 90 days
Our tracked history has 10 reports on PHAT from 8 analyst firms in the last 90 days (14 firms in the past year).
Comparing each firm's latest target with its previous one: 3 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Barclays lowered its target from $18.00 (set 27 Mar 2026) to $14.00 on 14 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Cantor Fitzgerald | Kristen Kluska | Buy | 24 Apr 2026 | 29.00 USD |
| Citigroup | Unnamed analyst | Buy | 30 Oct 2026 | — |
| Craig-Hallum | Chase Knickerbocker | Buy | 21 Oct 2026 | 15.00 USD |
| Goldman Sachs | Paul K Choi | Hold | 26 Feb 2026 | 13.00 USD |
| Guggenheim | Yastin Suneja | Buy | 31 Jul 2026 | 22.00 USD |
| H.C. Wainwright | Matthew Caufield | Buy | 30 Oct 2026 | 26.00 USD · 21 Sep 2026 |
| Jefferies | Dennis Ding | Buy | 14 Oct 2026 | 16.00 USD |
| Jefferies | Glen Santangelo | Buy | 14 Oct 2026 | 16.00 USD |
| Leerink Partners | Daniel Clark | Hold | 9 Sep 2026 | 10.00 USD |
| Needham | Joseph Stringer | Buy | 30 Jul 2026 | 22.00 USD |
| Raymond James | Martin Auster | Buy | 29 Oct 2026 | 28.00 USD · 11 Dec 2025 |
| Stifel | Annabel Samimy | — | 26 Feb 2026 | 28.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:58 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.